Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label Study

Leukocytapheresis (LCAP) has been advocated as a treatment for moderate to severe active ulcerative colitis (UC) in Japan. To clarify the predictive factors for a rapid response to LCAP treatment, we conducted a multicenter prospective open‐label study. A total of 105 patients with UC were analyzed....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic apheresis and dialysis 2008-12, Vol.12 (6), p.484-490
Hauptverfasser: Matsumoto, Takayuki, Andoh, Akira, Okawa, Kiyotaka, Ito, Hiroaki, Torii, Ayao, Yoshikawa, Syusaku, Nakaoka, Ryosuke, Okuyama, Yusuke, Oshitani, Nobuhide, Nishishita, Masakazu, Watanabe, Kenji, Fukunaga, Ken, Ohnishi, Kunio, Kusaka, Takeshi, Yokoyama, Yoko, Sasaki, Masaya, Tsujikawa, Tomoyuki, Aoki, Tetsuya, Kusaka, Toshihiro, Takeda, Yasuhiro, Umehara, Yasushi, Nakamura, Shiro, Fujiyama, Yoshihide
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 490
container_issue 6
container_start_page 484
container_title Therapeutic apheresis and dialysis
container_volume 12
creator Matsumoto, Takayuki
Andoh, Akira
Okawa, Kiyotaka
Ito, Hiroaki
Torii, Ayao
Yoshikawa, Syusaku
Nakaoka, Ryosuke
Okuyama, Yusuke
Oshitani, Nobuhide
Nishishita, Masakazu
Watanabe, Kenji
Fukunaga, Ken
Ohnishi, Kunio
Kusaka, Takeshi
Yokoyama, Yoko
Sasaki, Masaya
Tsujikawa, Tomoyuki
Aoki, Tetsuya
Kusaka, Toshihiro
Takeda, Yasuhiro
Umehara, Yasushi
Nakamura, Shiro
Fujiyama, Yoshihide
description Leukocytapheresis (LCAP) has been advocated as a treatment for moderate to severe active ulcerative colitis (UC) in Japan. To clarify the predictive factors for a rapid response to LCAP treatment, we conducted a multicenter prospective open‐label study. A total of 105 patients with UC were analyzed. LCAP was performed using a Cellsorba EX column once a week for 5–10 sessions. The response was evaluated by the clinical activity index (CAI). When the CAI score decreased to less than half the pretreatment value or to less than 5 points within 3 weeks, the patient was considered to be a rapid responder. The average CAI significantly decreased from 11.7 to 4.2 (P 
doi_str_mv 10.1111/j.1744-9987.2008.00639.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69954616</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20304692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4599-1436693fee6b6c522d48c67a2ae9f679b11999920f93cae361baa870b8b8e7b73</originalsourceid><addsrcrecordid>eNqNkc-O0zAQhyMEYpeFV0A-cUuw49SOEZeqogtS6Vb7RytxsRxnwrqbxlnbWdrX4glx2qocYS62NN9vxtaXJIjgjMT6uM4IL4pUiJJnOcZlhjGjItu-SM5PjZenOxdnyRvv1xjneUHp6-SMCFLgsuDnye_vQxvMs3JGBUDTTrU7bzxqrENzpYN1Hq0c1EYH0_1E16o3NboG39vOA7INWsDwaPUuqP4BHIxR06GVCga64NG9CQ_oJoCzpk737aC6gO5aDS4yz4BmtjXB-E9oivYv0TEHLu60vge9R6566NJWVdDGUUO9e5u8alTr4d3xvEju5l9uZ1_TxdXlt9l0kepiIkRKCsqYoA0Aq5ie5HldlJpxlSsQDeOiIkTEynEjqFZAGamUKjmuyqoEXnF6kXw4zO2dfRrAB7kxXkPbqg7s4CUTYlIwwv4J5pjigok8guUB1PF73kEje2c2yu0kwXIUK9dydCZHf3IUK_di5TZG3x93DNUG6r_Bo8kIfD4Av0wLu_8eLG-nq3iJ8fQQj4pge4or9ygZp3wi75eXckFvlvjHci4Z_QNhncUZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20304692</pqid></control><display><type>article</type><title>Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label Study</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Matsumoto, Takayuki ; Andoh, Akira ; Okawa, Kiyotaka ; Ito, Hiroaki ; Torii, Ayao ; Yoshikawa, Syusaku ; Nakaoka, Ryosuke ; Okuyama, Yusuke ; Oshitani, Nobuhide ; Nishishita, Masakazu ; Watanabe, Kenji ; Fukunaga, Ken ; Ohnishi, Kunio ; Kusaka, Takeshi ; Yokoyama, Yoko ; Sasaki, Masaya ; Tsujikawa, Tomoyuki ; Aoki, Tetsuya ; Kusaka, Toshihiro ; Takeda, Yasuhiro ; Umehara, Yasushi ; Nakamura, Shiro ; Fujiyama, Yoshihide</creator><creatorcontrib>Matsumoto, Takayuki ; Andoh, Akira ; Okawa, Kiyotaka ; Ito, Hiroaki ; Torii, Ayao ; Yoshikawa, Syusaku ; Nakaoka, Ryosuke ; Okuyama, Yusuke ; Oshitani, Nobuhide ; Nishishita, Masakazu ; Watanabe, Kenji ; Fukunaga, Ken ; Ohnishi, Kunio ; Kusaka, Takeshi ; Yokoyama, Yoko ; Sasaki, Masaya ; Tsujikawa, Tomoyuki ; Aoki, Tetsuya ; Kusaka, Toshihiro ; Takeda, Yasuhiro ; Umehara, Yasushi ; Nakamura, Shiro ; Fujiyama, Yoshihide</creatorcontrib><description>Leukocytapheresis (LCAP) has been advocated as a treatment for moderate to severe active ulcerative colitis (UC) in Japan. To clarify the predictive factors for a rapid response to LCAP treatment, we conducted a multicenter prospective open‐label study. A total of 105 patients with UC were analyzed. LCAP was performed using a Cellsorba EX column once a week for 5–10 sessions. The response was evaluated by the clinical activity index (CAI). When the CAI score decreased to less than half the pretreatment value or to less than 5 points within 3 weeks, the patient was considered to be a rapid responder. The average CAI significantly decreased from 11.7 to 4.2 (P &lt; 0.01). Seventy‐four percent of the patients responded to the therapy, and 53% of these patients were rapid responders. The following significant factors correlated with the rapid LCAP response: (i) steroid resistance (P &lt; 0.05), (ii) severe disease indicated by a CAI score greater than 11 (P = 0.05), (iii) disease duration of less than 1 year (P &lt; 0.05), and (iv) C‐reactive protein levels before treatment (P &lt; 0.01). These results suggest that the early initiation of LCAP is beneficial in patients with steroid‐resistant UC.</description><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/j.1744-9987.2008.00639.x</identifier><identifier>PMID: 19140847</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Adolescent ; Adult ; Aged ; Clinical activity index ; Colitis, Ulcerative - therapy ; Drug Resistance ; Female ; Forecasting ; Glucocorticoids - therapeutic use ; Humans ; Japan - epidemiology ; Leukapheresis ; Leukocytapheresis ; Male ; Middle Aged ; Multivariate Analysis ; Predictive factors ; Prospective Studies ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; Ulcerative colitis ; Young Adult</subject><ispartof>Therapeutic apheresis and dialysis, 2008-12, Vol.12 (6), p.484-490</ispartof><rights>2008 The Authors. Journal compilation © 2008 International Society for Apheresis</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4599-1436693fee6b6c522d48c67a2ae9f679b11999920f93cae361baa870b8b8e7b73</citedby><cites>FETCH-LOGICAL-c4599-1436693fee6b6c522d48c67a2ae9f679b11999920f93cae361baa870b8b8e7b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1744-9987.2008.00639.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1744-9987.2008.00639.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19140847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsumoto, Takayuki</creatorcontrib><creatorcontrib>Andoh, Akira</creatorcontrib><creatorcontrib>Okawa, Kiyotaka</creatorcontrib><creatorcontrib>Ito, Hiroaki</creatorcontrib><creatorcontrib>Torii, Ayao</creatorcontrib><creatorcontrib>Yoshikawa, Syusaku</creatorcontrib><creatorcontrib>Nakaoka, Ryosuke</creatorcontrib><creatorcontrib>Okuyama, Yusuke</creatorcontrib><creatorcontrib>Oshitani, Nobuhide</creatorcontrib><creatorcontrib>Nishishita, Masakazu</creatorcontrib><creatorcontrib>Watanabe, Kenji</creatorcontrib><creatorcontrib>Fukunaga, Ken</creatorcontrib><creatorcontrib>Ohnishi, Kunio</creatorcontrib><creatorcontrib>Kusaka, Takeshi</creatorcontrib><creatorcontrib>Yokoyama, Yoko</creatorcontrib><creatorcontrib>Sasaki, Masaya</creatorcontrib><creatorcontrib>Tsujikawa, Tomoyuki</creatorcontrib><creatorcontrib>Aoki, Tetsuya</creatorcontrib><creatorcontrib>Kusaka, Toshihiro</creatorcontrib><creatorcontrib>Takeda, Yasuhiro</creatorcontrib><creatorcontrib>Umehara, Yasushi</creatorcontrib><creatorcontrib>Nakamura, Shiro</creatorcontrib><creatorcontrib>Fujiyama, Yoshihide</creatorcontrib><title>Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label Study</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><description>Leukocytapheresis (LCAP) has been advocated as a treatment for moderate to severe active ulcerative colitis (UC) in Japan. To clarify the predictive factors for a rapid response to LCAP treatment, we conducted a multicenter prospective open‐label study. A total of 105 patients with UC were analyzed. LCAP was performed using a Cellsorba EX column once a week for 5–10 sessions. The response was evaluated by the clinical activity index (CAI). When the CAI score decreased to less than half the pretreatment value or to less than 5 points within 3 weeks, the patient was considered to be a rapid responder. The average CAI significantly decreased from 11.7 to 4.2 (P &lt; 0.01). Seventy‐four percent of the patients responded to the therapy, and 53% of these patients were rapid responders. The following significant factors correlated with the rapid LCAP response: (i) steroid resistance (P &lt; 0.05), (ii) severe disease indicated by a CAI score greater than 11 (P = 0.05), (iii) disease duration of less than 1 year (P &lt; 0.05), and (iv) C‐reactive protein levels before treatment (P &lt; 0.01). These results suggest that the early initiation of LCAP is beneficial in patients with steroid‐resistant UC.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Clinical activity index</subject><subject>Colitis, Ulcerative - therapy</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>Forecasting</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Leukapheresis</subject><subject>Leukocytapheresis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Predictive factors</subject><subject>Prospective Studies</subject><subject>Severity of Illness Index</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Ulcerative colitis</subject><subject>Young Adult</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc-O0zAQhyMEYpeFV0A-cUuw49SOEZeqogtS6Vb7RytxsRxnwrqbxlnbWdrX4glx2qocYS62NN9vxtaXJIjgjMT6uM4IL4pUiJJnOcZlhjGjItu-SM5PjZenOxdnyRvv1xjneUHp6-SMCFLgsuDnye_vQxvMs3JGBUDTTrU7bzxqrENzpYN1Hq0c1EYH0_1E16o3NboG39vOA7INWsDwaPUuqP4BHIxR06GVCga64NG9CQ_oJoCzpk737aC6gO5aDS4yz4BmtjXB-E9oivYv0TEHLu60vge9R6566NJWVdDGUUO9e5u8alTr4d3xvEju5l9uZ1_TxdXlt9l0kepiIkRKCsqYoA0Aq5ie5HldlJpxlSsQDeOiIkTEynEjqFZAGamUKjmuyqoEXnF6kXw4zO2dfRrAB7kxXkPbqg7s4CUTYlIwwv4J5pjigok8guUB1PF73kEje2c2yu0kwXIUK9dydCZHf3IUK_di5TZG3x93DNUG6r_Bo8kIfD4Av0wLu_8eLG-nq3iJ8fQQj4pge4or9ygZp3wi75eXckFvlvjHci4Z_QNhncUZ</recordid><startdate>200812</startdate><enddate>200812</enddate><creator>Matsumoto, Takayuki</creator><creator>Andoh, Akira</creator><creator>Okawa, Kiyotaka</creator><creator>Ito, Hiroaki</creator><creator>Torii, Ayao</creator><creator>Yoshikawa, Syusaku</creator><creator>Nakaoka, Ryosuke</creator><creator>Okuyama, Yusuke</creator><creator>Oshitani, Nobuhide</creator><creator>Nishishita, Masakazu</creator><creator>Watanabe, Kenji</creator><creator>Fukunaga, Ken</creator><creator>Ohnishi, Kunio</creator><creator>Kusaka, Takeshi</creator><creator>Yokoyama, Yoko</creator><creator>Sasaki, Masaya</creator><creator>Tsujikawa, Tomoyuki</creator><creator>Aoki, Tetsuya</creator><creator>Kusaka, Toshihiro</creator><creator>Takeda, Yasuhiro</creator><creator>Umehara, Yasushi</creator><creator>Nakamura, Shiro</creator><creator>Fujiyama, Yoshihide</creator><general>Blackwell Publishing Asia</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200812</creationdate><title>Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label Study</title><author>Matsumoto, Takayuki ; Andoh, Akira ; Okawa, Kiyotaka ; Ito, Hiroaki ; Torii, Ayao ; Yoshikawa, Syusaku ; Nakaoka, Ryosuke ; Okuyama, Yusuke ; Oshitani, Nobuhide ; Nishishita, Masakazu ; Watanabe, Kenji ; Fukunaga, Ken ; Ohnishi, Kunio ; Kusaka, Takeshi ; Yokoyama, Yoko ; Sasaki, Masaya ; Tsujikawa, Tomoyuki ; Aoki, Tetsuya ; Kusaka, Toshihiro ; Takeda, Yasuhiro ; Umehara, Yasushi ; Nakamura, Shiro ; Fujiyama, Yoshihide</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4599-1436693fee6b6c522d48c67a2ae9f679b11999920f93cae361baa870b8b8e7b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Clinical activity index</topic><topic>Colitis, Ulcerative - therapy</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>Forecasting</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Leukapheresis</topic><topic>Leukocytapheresis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Predictive factors</topic><topic>Prospective Studies</topic><topic>Severity of Illness Index</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Ulcerative colitis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsumoto, Takayuki</creatorcontrib><creatorcontrib>Andoh, Akira</creatorcontrib><creatorcontrib>Okawa, Kiyotaka</creatorcontrib><creatorcontrib>Ito, Hiroaki</creatorcontrib><creatorcontrib>Torii, Ayao</creatorcontrib><creatorcontrib>Yoshikawa, Syusaku</creatorcontrib><creatorcontrib>Nakaoka, Ryosuke</creatorcontrib><creatorcontrib>Okuyama, Yusuke</creatorcontrib><creatorcontrib>Oshitani, Nobuhide</creatorcontrib><creatorcontrib>Nishishita, Masakazu</creatorcontrib><creatorcontrib>Watanabe, Kenji</creatorcontrib><creatorcontrib>Fukunaga, Ken</creatorcontrib><creatorcontrib>Ohnishi, Kunio</creatorcontrib><creatorcontrib>Kusaka, Takeshi</creatorcontrib><creatorcontrib>Yokoyama, Yoko</creatorcontrib><creatorcontrib>Sasaki, Masaya</creatorcontrib><creatorcontrib>Tsujikawa, Tomoyuki</creatorcontrib><creatorcontrib>Aoki, Tetsuya</creatorcontrib><creatorcontrib>Kusaka, Toshihiro</creatorcontrib><creatorcontrib>Takeda, Yasuhiro</creatorcontrib><creatorcontrib>Umehara, Yasushi</creatorcontrib><creatorcontrib>Nakamura, Shiro</creatorcontrib><creatorcontrib>Fujiyama, Yoshihide</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsumoto, Takayuki</au><au>Andoh, Akira</au><au>Okawa, Kiyotaka</au><au>Ito, Hiroaki</au><au>Torii, Ayao</au><au>Yoshikawa, Syusaku</au><au>Nakaoka, Ryosuke</au><au>Okuyama, Yusuke</au><au>Oshitani, Nobuhide</au><au>Nishishita, Masakazu</au><au>Watanabe, Kenji</au><au>Fukunaga, Ken</au><au>Ohnishi, Kunio</au><au>Kusaka, Takeshi</au><au>Yokoyama, Yoko</au><au>Sasaki, Masaya</au><au>Tsujikawa, Tomoyuki</au><au>Aoki, Tetsuya</au><au>Kusaka, Toshihiro</au><au>Takeda, Yasuhiro</au><au>Umehara, Yasushi</au><au>Nakamura, Shiro</au><au>Fujiyama, Yoshihide</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label Study</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2008-12</date><risdate>2008</risdate><volume>12</volume><issue>6</issue><spage>484</spage><epage>490</epage><pages>484-490</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><abstract>Leukocytapheresis (LCAP) has been advocated as a treatment for moderate to severe active ulcerative colitis (UC) in Japan. To clarify the predictive factors for a rapid response to LCAP treatment, we conducted a multicenter prospective open‐label study. A total of 105 patients with UC were analyzed. LCAP was performed using a Cellsorba EX column once a week for 5–10 sessions. The response was evaluated by the clinical activity index (CAI). When the CAI score decreased to less than half the pretreatment value or to less than 5 points within 3 weeks, the patient was considered to be a rapid responder. The average CAI significantly decreased from 11.7 to 4.2 (P &lt; 0.01). Seventy‐four percent of the patients responded to the therapy, and 53% of these patients were rapid responders. The following significant factors correlated with the rapid LCAP response: (i) steroid resistance (P &lt; 0.05), (ii) severe disease indicated by a CAI score greater than 11 (P = 0.05), (iii) disease duration of less than 1 year (P &lt; 0.05), and (iv) C‐reactive protein levels before treatment (P &lt; 0.01). These results suggest that the early initiation of LCAP is beneficial in patients with steroid‐resistant UC.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>19140847</pmid><doi>10.1111/j.1744-9987.2008.00639.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1744-9979
ispartof Therapeutic apheresis and dialysis, 2008-12, Vol.12 (6), p.484-490
issn 1744-9979
1744-9987
language eng
recordid cdi_proquest_miscellaneous_69954616
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
Aged
Clinical activity index
Colitis, Ulcerative - therapy
Drug Resistance
Female
Forecasting
Glucocorticoids - therapeutic use
Humans
Japan - epidemiology
Leukapheresis
Leukocytapheresis
Male
Middle Aged
Multivariate Analysis
Predictive factors
Prospective Studies
Severity of Illness Index
Time Factors
Treatment Outcome
Ulcerative colitis
Young Adult
title Multivariate Analysis for Factors Predicting Rapid Response of Leukocytapheresis in Patients With Steroid-resistant Ulcerative Colitis: A Multicenter Prospective Open-label Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A42%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multivariate%20Analysis%20for%20Factors%20Predicting%20Rapid%20Response%20of%20Leukocytapheresis%20in%20Patients%20With%20Steroid-resistant%20Ulcerative%20Colitis:%20A%20Multicenter%20Prospective%20Open-label%20Study&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Matsumoto,%20Takayuki&rft.date=2008-12&rft.volume=12&rft.issue=6&rft.spage=484&rft.epage=490&rft.pages=484-490&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/j.1744-9987.2008.00639.x&rft_dat=%3Cproquest_cross%3E20304692%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20304692&rft_id=info:pmid/19140847&rfr_iscdi=true